Virtual event

Labroots Announces 13th Annual Virtual Clinical Diagnostics and Research Event to be Held November 9, 2022

Leading experts will explore advances and new technologies in clinical diagnostics for the early detection, treatment and prevention of disease at this free online event

YORBA LINDA, Calif., November 32022 /PRNewswire-PRWeb/ — Labroots, the leading scientific social networking website offering premier virtual events and interactive webinars, today announced its 13th annual Clinical Diagnostics and Research virtual event. On November 9an audience of clinicians, researchers, top scientists, academics, and industry and pharmaceutical and biotech professionals will come together under one virtual roof to learn from recognized speakers who are driving innovation in diagnostics and precision medicine.

For more than a decade, this online event has been a favorite meeting place for the clinical diagnostic, research and laboratory medicine communities. And, once again, Labroots’ Clinical Diagnostics & Research 2022 program will deliver on its commitment to scientific breakthrough in the areas of emerging diagnostic technologies, insights into SARS-CoV-2 and Monkeypox, precision medicine and special populations, and the role of the laboratory in promoting equity . Don’t miss a minute of the cutting-edge 4-track science agenda with convenient on-demand viewing.

Educational program highlights include (but are not limited to):

  • Keynote presentation titled “Implementing Serological and Molecular Tools to Inform COVID-19 Patient Management,” with a live Q&A session, presented by Dr. Jennifer Taher. “Although several years have passed since the start of the COVID-19 pandemic, there are still many things we don’t know,” commented Dr. Jennifer Taher, FCACB, Clinical Biochemist, Mount Sinai Hospital, Pathology and Laboratory Medicine; assistant professor, University of Toronto, laboratory medicine and pathobiology, co-head, GENCOV. “It is important to identify groups at risk of poor outcomes and to optimize patient care. This is exactly what the GENCOV study aims to do.”

  • Easily on-demand presentations for immediate viewing when the event is live regarding some discussions on the benefits of having faster next-generation sequencing data in outbreak settings, the use of PCR tiling for sequencing of Monkeypox, methods used in the detection of autoantibodies associated with IIM, fairness in laboratory medicine, and the Monkeypox virus and its current epidemic characteristics.

  • The benefits of bioinformatics solutions and computational variant classification will be explored, and how to move towards comprehensive profiling while reducing costs, time and labor during QIAGEN sponsored presentations.

  • Multiple panel presentations sponsored by Thermo Fisher Scientific on topics spanning ART adherence disruption and impact on emerging antiretroviral drug resistance mutations, the current state of the molecular testing market with a key focus on pharmacogenomics, integrase-targeting HIV-1 genotyping – insights into antiretroviral drug resistance surveillance and the technical challenges of standard urine culture (SUC) in the identification of uropathogens, and much more!

Produced on Labroots’ robust platform, this online event allows attendees to connect seamlessly across desktop and mobile devices and provides a comprehensive educational experience. The interactive environment includes a lobby equipped with leaderboard and gamification, an auditorium featuring live video webcasts with live attendee discussions during scheduled presentations, an exhibit hall to interact with sponsors highlighting their recent contributions to the field, a poster room to explore date and engage in live chat conversations with a poster contest, and a networking lounge to encourage collaborations with colleagues. By participating, it is possible to earn up to 1 PACE continuing education credit per presentation for a maximum of 30 credits. To register for the event, click here.

Don’t forget to use the hashtag #LRclinical to follow the conversation and connect with other members of the global Clinical & Molecular Dx community!

Follow @Diagnostics_LR on Twitter and @ClinicalandMolecularDiagnostics.LR on Facebook to connect with our Clinical and Molecular Dx editors and stay up to date on the latest trends in Clinical and Molecular Dx. Join our Clinical & Molecular Dx interest group on LinkedIn to connect with us and the wider professional community!

About Labroots
Labroots is the leading science social networking website and leading source for science news and leading virtual events and educational webinars and more. Advancing science through content sharing capabilities, Labroots is a powerful advocate for amplifying global networks and communities. Founded in 2008, Labroots focuses on digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay at the top of their field by earning continuing education credits on a wide range of topics through their participation in webinars and virtual events. Today, Labroots delivers more than ever with Chati, a flexible and highly scalable event platform that enables the creation of unique, effective and memorable virtual events.

Media Contact

Lynn BrainardLabroots, 714-771-4397, [email protected]

Twitter

SOURCE Lab